Jobubu Jarum Minahasa Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Jobubu Jarum Minahasa Tbk trades at Rp81 (market cap 324B, 5.1M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Jobubu Jarum Minahasa Tbk is the larger of the two by market cap, and Jobubu Jarum Minahasa Tbk is more actively traded (5.1M versus 214.9K). Which is the better fit depends on your goals.
| BEER | OBAT | |
|---|---|---|
Market Cap | 324B | 164.65B |
Volume | 5.1M | 214.9K |
Lot | 50.98K | 2.15K |
Turnover | 402.52M | 51.97M |
Average Price | 78.96 | 241.85 |
Value | 402.52M | 51.97M |
Indicative Equilibrium Price | 81 | 240 |
Indicative Equilibrium Volume | 250 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Jobubu Jarum Minahasa Tbk (the “Company”) was established based on Notarial Deed No. 19 of Theomaris Eddy Boham, S.H., M.H., dated July 25, 2018. The Company started its commercial operations since December 2018. The majority shareholder of the Company is PT Maju Minuman Minahasa and the Company's Ultimate Beneficiary Owner (UBO) is Nico Lieke.
Read more on BEER →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →